研究文章
淋巴细胞亚群分析和细胞因子在COVID-19-Associated肺炎和社区获得性肺炎
|
| 变量 |
帽(
) |
COVID-19 (
) |
|
|
| 年龄(年) |
50 (32 - 72) |
53 (41 - 64) |
0.230 |
| 性别(M / F) |
80/50 |
152/144 |
0.057 |
| CD3+ |
936.37 (322.75 - -1187.5) |
973.11 (596.75 -1274) |
0.673 |
| CD19+ |
248.5 (55.25 - -285.5) |
184.43 (92 - 246) |
0.152 |
| CD3+CD4+ |
426.42 (133.25 - -580.25) |
579.1 (334 - 766.5) |
< 0.001 |
| CD3+CD8+ |
462.48 (123.75 - -540.75) |
368.9 (212.75 -488) |
0.106 |
| CD16+CD56+ |
183.98 (64.25 - -227.5) |
238.59 (107.75 - -304.25) |
0.007 |
| 4/8的比例 |
1.47 (0.57 - -1.73) |
1.81 (1.19 - -2.21) |
0.015 |
| CD3+% lym |
67.5 (60.1 - -77.19) |
67.8 (62.43 - -74.87) |
0.802 |
| CD19+% lym |
16.69 (7.41 - -22.32) |
14 (8.6 - -17.8) |
0.024 |
| CD3+CD4+% lym |
31.79 (21.81 - -39.57) |
40.38 (33.72 - -46.49) |
< 0.001 |
| CD3+CD8+% lym |
31.87 (21.18 - -39.42) |
25.7 (20 - 31.4) |
< 0.001 |
| CD16+CD56+% lym |
14.6 (7.21 - -19.4) |
16.75 (9.68 - -22.2) |
0.038 |
|
|
